-
July 21, 2021 Interview With Jemie Sae KooIn this episode of the Psychedelic Spotlight podcast, we feature Jemie Sae Koo, CEO and...
-
July 14, 2021 BIG UPDATE On The LARGEST Psychedelic Therapy Clinical Trial: CMPS’ Psilocybin-Depression StudyHUGE UPDATE: Compass Pathways, (NASDAQ: CMPS), completes the LARGEST Phase 2b psilocybin clinical study to...
-
July 14, 2021 Interview With Daniel CarcilloIn this episode of the Psychedelic Spotlight podcast we catch up with Daniel Carcillo, Founder...
-
July 11, 2021 Numinus CEO Discussion: a LEADER in Psychedelic-Assisted Therapy? ( NUMI / LKYSF Stock)Numinus Wellness (TSX.V: NUMI), (OTC: LKYSF), has been a constant topic of conversation on this...
-
July 9, 2021 Interview With Anthony TennysonWe speak with Anthony Tennyson, CEO of Awakn Life Sciences, a biotechnology company with clinical...
-
July 9, 2021 Numinus & Cybin Forge MASSIVE DEALS ( NUMI / CYBN )BIG news for Cybin Inc. (CYBN: NEO) (CLXPF: OTC) and Numinus Wellness (NUMI: NEO) (LKYSF:...
-
July 4, 2021 Can TRYP Therapeutics Treat Chronic Pain and Eating Disorders With Psychedelics? (TRYP / TRYF)In today's episode, we'll be interviewing CEO and Chairman of TRYP Therapeutics, Greg Mckee. Thus...
-
June 30, 2021 Interview With Lauren TausIn this episode of the Psychedelic Spotlight podcast we speak with Lauren Taus who is...
-
June 30, 2021 Interview With Tesla La ToucheIn this episode of the Psychedelic Spotlight podcast, we spend some time with Tesla La...
-
June 29, 2021 Numinus’ BIG Patent, Mydecine Tackles A $13.6 BILLION Market & Some BUY Ratings! ( NUMI / MYCO)BIG news for Mydecine (MYCO : NEO) (MYCOF: OTC) and Numinus Wellness (NUMI: NEO) (LKYSF...
